Michelle Tolley was told by her treating hospital that only eight people were able to receive treatment with DAAs per month. Initially she was eligible for treatment. However, she then was told that due to the hospital losing funding, the number of patients eligible for treatment reduced from eight to two and she was no longer able to receive it. Read more about Michelle Tolley was told by her treating hospital that only eight people were able to receive treatment with DAAs per month. Initially she was eligible for treatment. However, she then was told that due to the hospital losing funding, the number of patients eligible for treatment reduced from eight to two and she was no longer able to receive it.
Christopher Meaden described his mother's difficulties accessing treatment with interferon, ribavirin and telaprevir in Wales. Read more about Christopher Meaden described his mother's difficulties accessing treatment with interferon, ribavirin and telaprevir in Wales.
Thomas Farrell was told at the age of 64, he was too old to receive treatment for Hepatitis C, however, after contacting his GP, he was able to start a one-year course of Interferon. Read more about Thomas Farrell was told at the age of 64, he was too old to receive treatment for Hepatitis C, however, after contacting his GP, he was able to start a one-year course of Interferon.
A witness described not being aware of, or offered, treatment for Hepatitis C until 2006 when he was treated with combination therapy of interferon and ribavirin. Read more about A witness described not being aware of, or offered, treatment for Hepatitis C until 2006 when he was treated with combination therapy of interferon and ribavirin.
Leigh Day solicitors submitted to the Inquiry that one of the most important issues for them in relation to their treatment was their ability to access monitoring and follow-up care for Hepatitis C (and related symptoms and conditions) after they achieved a sustained virological response, and had thus apparently "cleared" the virus. Read more about Leigh Day solicitors submitted to the Inquiry that one of the most important issues for them in relation to their treatment was their ability to access monitoring and follow-up care for Hepatitis C (and related symptoms and conditions) after they achieved a sustained virological response, and had thus apparently "cleared" the virus.
Caroline Leonard explained that in Northern Ireland patients who have a fibroscan suggestive of advanced fibrosis or cirrhosis are kept under long-term review at the liver clinic, with an ultrasound and blood test for AFP every six months and a six-monthly clinic review. Read more about Caroline Leonard explained that in Northern Ireland patients who have a fibroscan suggestive of advanced fibrosis or cirrhosis are kept under long-term review at the liver clinic, with an ultrasound and blood test for AFP every six months and a six-monthly clinic review.
Caroline Leonard explained all NICE approved specialist drug therapies are available for Hepatitis C in Northern Ireland. Read more about Caroline Leonard explained all NICE approved specialist drug therapies are available for Hepatitis C in Northern Ireland.
Caroline Leonard, on behalf of the Belfast Health and Social Care Trust, acknowledged that patients had had to wait, both for a hepatology referral and for treatment. By Autumn 2019, the waiting time for someone with HCV to be seen at clinic was reduced to around 8 weeks. Read more about Caroline Leonard, on behalf of the Belfast Health and Social Care Trust, acknowledged that patients had had to wait, both for a hepatology referral and for treatment. By Autumn 2019, the waiting time for someone with HCV to be seen at clinic was reduced to around 8 weeks.
Julie Morgan MS, who campaigned on behalf of haemophilia patients in Parliament and then the Senedd, described access to Hepatitis C treatment in Wales as having been a "postcode lottery" but the announcement of £13.8 million for interferon-free treatment was a turning point. Read more about Julie Morgan MS, who campaigned on behalf of haemophilia patients in Parliament and then the Senedd, described access to Hepatitis C treatment in Wales as having been a "postcode lottery" but the announcement of £13.8 million for interferon-free treatment was a turning point.
Kenneth Gray said he and his late wife would have self-funded Hepatitis C treatment if they had known it was possible, in order to have more time together. Read more about Kenneth Gray said he and his late wife would have self-funded Hepatitis C treatment if they had known it was possible, in order to have more time together.